Table 4.
Final diagnosis and modality | True positive | False negative | Total |
---|---|---|---|
Malignant neoplasms | |||
VCE | 11 (84.6) | 2 (15.4) | 13 |
MR enteroclysis | 13 (100.0) | 0 (0.0) | 13 |
Benign neoplasms | |||
VCE | 7 (70.0) | 3 (30.0) | 10 |
MR enteroclysis | 9 (90.0) | 1 (10.0) | 10 |
Refractory celiac disease | |||
VCE | 4 (100.0) | 0 (0.0) | 4 |
MR enteroclysis | 3 (75.0) | 1 (25.0) | 4 |
Crohn’s disease | |||
VCE | 0 (0.0) | 2 (100.0) | 2 |
MR enteroclysis | 2 (100.0) | 0 (0.0) | 2 |
Vascular malformations | |||
VCE | 1 (100.0) | 0 (0.0) | 1 |
MR enteroclysis | 0 (0.0) | 1 (100.0) | 1 |
Other conditions | |||
VCE | 6 (66.7) | 3 (33.3) | 9 |
MR enteroclysis | 4 (44.4) | 5 (55.6) | 9 |
All data are number of patients, with percentages between parentheses
VCE, video capsule endoscopy